Edit
Life Sciences Greenhouse of Central Pennsylvania
https://www.lsgpa.comLast activity: 02.02.2022
Active
A Venture Capital Investment Company for Life Sciences Enterprises in Central Pennsylvania
Employees: 1-10
Investment Type: Venture Capital
Portfolio 10
| Date | Name | Website | Total Raised | Location |
| 01.07.2022 | Avisi | avisitech.com | $5.1M | United Sta... |
| - | MacuLogix ... | maculogix.com | $57.3M | United Sta... |
| - | Saladax Bi... | saladax.com | $30.4M | United Sta... |
| - | Emma Healt... | inrangesystems.com | - | - |
| - | Immunomic ... | immunomix.com | $64.3M | United Sta... |
| - | Micro Inte... | microinterventional.com | $25.35M | - |
| - | INDIGO Bio... | indigobiosciences.com | $500K | United Sta... |
| - | Azevan Pha... | azevan.com | - | China |
| - | QuantumBio... | quantumbioinc.com | - | United Sta... |
| - | ChromaTan ... | chromatan.com | $2M | - |
Mentions in press and media 10
| Date | Title | Description |
| 07.02.2018 | Biotech with treatment for chronic dry eye disease tied to diabetes raises seed capital | The $500,000 seed round comes from two funding sources supported by Pennsylvania: Life Sciences Greenhouse of Central Pennsylvania (LSGCP) and a branch of the state economic development arm Ben Franklin Technology Partners/Central and North... |
| 23.10.2013 | Innovate in PA legislation will bring 1,850 tech jobs to state: Tom Corbett | Gov. Tom Corbett visited the Navy Yard last week to trump the Innovate in PA legislation he signed this summer aimed at bringing more than $75 million in early stage investment to the state as soon as next year. He was hosted by the Ben Fra... |
| 06.08.2012 | Minimally invasive heart surgery device gets follow-on investment from Pa. economic development agency | In addition to Ben Franklin Technology Partners of Northeastern Pennsylvania, other investors have included Life Sciences Greenhouse of Central Pennsylvania, Battelle Ventures and New Hope Ventures. The device is applied to the myocardium b... |
| 10.05.2012 | Minimally invasive cardiac surgery closure device to cut recovery times | Micro Interventional Devices’ lead device, Permaseal ,uses a sutureless technology to repair the access point of the procedure and closes using a combination of soft tissue anchors and biocompatible elastomers that produce a web structure a... |
| 01.03.2012 | Micro Interventional Devices Raises $250K in Funding | Micro Interventional Devices, Inc. (MID), a Bethlehem, PA-based developer of structural heart repair technologies, has raised $250k in funding from The Life Sciences Greenhouse of Central Pennsylvania. Founded in May of 2010 and led by Pres... |
| 30.01.2012 | FDA-approved device to detect macular degeneration raising $2 million | Although there is no cure for macular degeneration, early detection of the disease, which generally occurs after age 50, is critical to avoid or at least delay the onset of blindness. The disease affects 30 million people globally. Frost &a... |
| - | Minimally invasive heart surgery device gets follow-on investment from Pa. economic development agency | A company with a suture-less closure device for heart surgery procedures intended to reduce blood loss and the amount of time the patient spends on the operating table has received follow-on investment from Ben Franklin Technology Partners ... |
| - | Minimally invasive cardiac surgery closure device to cut recovery times | As the trend toward minimally invasive cardiac surgery grows, a cardiac medical device startup has developed a sutureless closure device to facilitate transcatheter aortic valve implantation that could cut recovery times and reduce hospital... |
| - | FDA-approved device to detect macular degeneration raising $2 million | A company with a medical device to detect early onset of age-related macular degeneration, the leading cause of blindness in adults ages 50 or older, is raising $2 million in a series A preferred financing round to commercialize its diagnos... |
| - | Biotech with treatment for chronic dry eye disease tied to diabetes raises seed capital | Biotech startup Ocunova, a spin-out from the Penn State University College of Medicine, has closed a fresh round of seed funding to support clinical trials for a treatment aimed at a chronic dry eye condition related to diabetes. The treatm... |